Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Cited In for PubMed (Select 17651705)


Atypical antipsychotics in the treatment of early-onset schizophrenia.

Hrdlicka M, Dudova I.

Neuropsychiatr Dis Treat. 2015 Apr 1;11:907-13. doi: 10.2147/NDT.S82185. eCollection 2015. Review.


Clozapine is underutilized.

Kane JM.

Shanghai Arch Psychiatry. 2012 Apr;24(2):114-5. doi: 10.3969/j.issn.1002-0829.2012.02.008. No abstract available.


The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.

Hayes RD, Downs J, Chang CK, Jackson RG, Shetty H, Broadbent M, Hotopf M, Stewart R.

Schizophr Bull. 2015 May;41(3):644-55. doi: 10.1093/schbul/sbu120. Epub 2014 Aug 25.


Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.

Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg-Olesen M, Jantzen P, Rasmussen S, Saldeen EA, Lauritsen MB, Bilenberg N, Stenstrøm AD, Pedersen J, Nyvang L, Madsen S, Lauritsen MB, Vernal DL, Thomsen PH, Paludan J, Werge TM, Winge K, Juul K, Gluud C, Skoog M, Wetterslev J, Jepsen JR, Correll CU, Fink-Jensen A, Fagerlund B.

BMC Psychiatry. 2014 Jul 11;14:199. doi: 10.1186/1471-244X-14-199.


Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia.

Hatta K, Ito H.

Clin Psychopharmacol Neurosci. 2014 Apr;12(1):1-7. doi: 10.9758/cpn.2014.12.1.1. Epub 2014 Apr 24. Review.


Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis.

Sarkar S, Grover S.

Indian J Pharmacol. 2013 Sep-Oct;45(5):439-46. doi: 10.4103/0253-7613.117720. Review.


Les recommandations de prise en charge des complications métaboliques associées aux antipsychotiques de deuxième génération chez les enfants et les adolescents.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T.

Paediatr Child Health. 2012 Oct;17(Suppl B):5B-11B. French.


Clinical features of schizophrenia with enhanced carbonyl stress.

Miyashita M, Arai M, Kobori A, Ichikawa T, Toriumi K, Niizato K, Oshima K, Okazaki Y, Yoshikawa T, Amano N, Miyata T, Itokawa M.

Schizophr Bull. 2014 Sep;40(5):1040-6. doi: 10.1093/schbul/sbt129. Epub 2013 Sep 23.


Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.

Findling RL, Pathak S, Earley WR, Liu S, DelBello M.

J Child Adolesc Psychopharmacol. 2013 Sep;23(7):490-501. doi: 10.1089/cap.2012.0092. Epub 2013 Sep 11.


Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods.

Jeon S, Walkup JT, Woods DW, Peterson A, Piacentini J, Wilhelm S, Katsovich L, McGuire JF, Dziura J, Scahill L.

Contemp Clin Trials. 2013 Nov;36(2):414-20. doi: 10.1016/j.cct.2013.08.012. Epub 2013 Aug 31.


Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.

Mondelli V, Anacker C, Vernon AC, Cattaneo A, Natesan S, Modo M, Dazzan P, Kapur S, Pariante CM.

Transl Psychiatry. 2013 Jan 15;3:e208. doi: 10.1038/tp.2012.138.


Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T; Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group.

Paediatr Child Health. 2011 Nov;16(9):575-80.


Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: systematic review.

[No authors listed]

CADTH Technol Overv. 2012;2(3):e2301. Epub 2012 Sep 1. No abstract available.


The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.

Abbs B, Achalia RM, Adelufosi AO, Aktener AY, Beveridge NJ, Bhakta SG, Blackman RK, Bora E, Byun MS, Cabanis M, Carrion R, Castellani CA, Chow TJ, Dmitrzak-Weglarz M, Gayer-Anderson C, Gomes FV, Haut K, Hori H, Kantrowitz JT, Kishimoto T, Lee FH, Lin A, Palaniyappan L, Quan M, Rubio MD, Ruiz de Azúa S, Sahoo S, Strauss GP, Szczepankiewicz A, Thompson AD, Trotta A, Tully LM, Uchida H, Velthorst E, Young JW, O'Shea A, Delisi LE.

Schizophr Res. 2012 Oct;141(1):e1-e24. doi: 10.1016/j.schres.2012.07.024. Epub 2012 Aug 19.


Treatment of early onset schizophrenia: recent trends, challenges and future considerations.

Vyas NS, Gogtay N.

Front Psychiatry. 2012 Apr 2;3:29. doi: 10.3389/fpsyt.2012.00029. eCollection 2012.


Semantic Processing and Thought Disorder in Childhood-Onset Schizophrenia: Insights from fMRI.

Borofsky LA, McNealy K, Siddarth P, Wu KN, Dapretto M, Caplan R.

J Neurolinguistics. 2010 May;23(3):204-222.


Management recommendations for metabolic complications associated with second generation antipsychotic use in children and youth.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T; CAMESA guideline group.

J Can Acad Child Adolesc Psychiatry. 2011 Aug;20(3):234-41.


Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.

Pringsheim T, Panagiotopoulos C, Davidson J, Ho J; CAMESA guideline group.

J Can Acad Child Adolesc Psychiatry. 2011 Aug;20(3):218-33. Erratum in: J Can Acad Child Adolesc Psychiatry. 2011 August;20(3):1–2..


Pharmacotherapy for treatment-resistant schizophrenia.

McIlwain ME, Harrison J, Wheeler AJ, Russell BR.

Neuropsychiatr Dis Treat. 2011;7:135-49. doi: 10.2147/NDT.S12769. Epub 2011 Mar 17.


Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.

Karmacharya R, Lynn SK, Demarco S, Ortiz A, Wang X, Lundy MY, Xie Z, Cohen BM, Miller GM, Buttner EA.

Brain Res. 2011 Jun 1;1393:91-9. doi: 10.1016/j.brainres.2011.04.010. Epub 2011 Apr 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk